Select a Sector or Industry
Cash and ST Investments Rankings for Biotechnology Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Cash and ST Investments
|
Pro Rating
|
|---|---|---|---|---|
| 1 | AMGN | Amgen | 19.37B | Go Pro |
| 2 | CELG | Celgene Corporation | 2.269B | Go Pro |
| 3 | GILD | Gilead Sciences | 1.452B | Go Pro |
| 4 | BIIB | Biogen Idec | 1.277B | Go Pro |
| 5 | ILMN | Illumina | 1.266B | Go Pro |
| 6 | VRTX | Vertex Pharmaceuticals | 1.039B | Go Pro |
| 7 | SHPGY | Shire | 894.30M | Go Pro |
| 8 | ONXX | ONYX Pharmaceuticals | 599.99M | Go Pro |
| 9 | DNDN | Dendreon Corporation | 497.54M | Go Pro |
| 10 | VPHM | ViroPharma | 473.36M | Go Pro |
| 11 | HGSI | Human Genome Sciences | 471.80M | Go Pro |
| 12 | REGN | Regeneron Pharmaceuticals | 432.30M | Go Pro |
| 13 | MNTA | Momenta Pharmaceuticals | 399.76M | Go Pro |
| 14 | NKTR | Nektar Therapeutics | 382.11M | Go Pro |
| 15 | MDVN | Medivation | 380.09M | Go Pro |
| 16 | ITMN | InterMune | 377.24M | Go Pro |
| 17 | ALXN | Alexion Pharmaceuticals | 359.39M | Go Pro |
| 18 | VVUS | Vivus | 333.40M | Go Pro |
| 19 | AMLN | Amylin Pharmaceuticals | 315.30M | Go Pro |
| 20 | SGEN | Seattle Genetics | 308.87M | Go Pro |
| 21 | ARIA | ARIAD Pharmaceuticals | 287.75M | Go Pro |
| 22 | ACOR | Acorda Therapeutics | 278.55M | Go Pro |
| 23 | INCY | Incyte Corporation | 255.71M | Go Pro |
| 24 | LXRX | Lexicon Pharmaceuticals | 253.66M | Go Pro |
| 25 | JAZZ | Jazz Pharmaceuticals | 244.22M | Go Pro |
| 26 | EXEL | Exelixis | 243.44M | Go Pro |
| 27 | BMRN | BioMarin Pharmaceutical | 232.98M | Go Pro |
| 28 | AVEO | AVEO Pharmaceuticals | 224.33M | Go Pro |
| 29 | QCOR | Questcor Pharmaceuticals | 223.66M | Go Pro |
| 30 | QLTI | QLT | 207.19M | Go Pro |
| 31 | THRX | Theravance | 200.16M | Go Pro |
| 32 | ALNY | Alnylam Pharmaceuticals | 199.10M | Go Pro |
| 33 | PDLI | PDL BioPharma | 187.38M | Go Pro |
| 34 | SPPI | Spectrum Pharmaceuticals | 186.32M | Go Pro |
| 35 | NBIX | Neurocrine Biosciences | 181.09M | Go Pro |
| 36 | TRGT | Targacept | 176.56M | Go Pro |
| 37 | IMGN | ImmunoGen | 175.58M | Go Pro |
| 38 | PACB | Pacific Biosciences of California | 161.35M | Go Pro |
| 39 | VNDA | Vanda Pharmaceuticals | 157.25M | Go Pro |
| 40 | EBS | Emergent BioSolutions | 150.42M | Go Pro |
| 41 | GEVA | Synageva BioPharma | 138.92M | Go Pro |
| 42 | NPSP | NPS Pharmaceuticals | 137.71M | Go Pro |
| 43 | SVNT | Savient Pharmaceuticals | 130.97M | Go Pro |
| 44 | ZIOP | Ziopharm Oncology | 128.01M | Go Pro |
| 45 | ENZN | Enzon Pharmaceuticals | 124.69M | Go Pro |
| 46 | GERN | Geron Corporation | 120.22M | Go Pro |
| 47 | SQNM | Sequenom | 119.91M | Go Pro |
| 48 | SSRX | 3SBio | 118.47M | Go Pro |
| 49 | HALO | Halozyme Therapeutics | 116.61M | Go Pro |
| 50 | OGXI | OncoGenex Pharmaceuticals | 111.70M | Go Pro |
